Safety issues of methylglyoxal and potential scavengers

Abstract

The health safety of methylglyoxal (MGO) has been recognized as a key issue owing to its ultra-high reactivity toward some key biomolecules such as amino acids, proteins, DNA, sulfhydryl- and basic nitrogen-containing compounds, including amino-bearing neurotransmitters. In this review, we have summarized the endo- and exogenous sources of MGO and its accumulation inside the body due to high intake, abnormal glucose metabolism and or malfunctioning glyoxalases, and review the debate concerning the adverse functionality of MGO ingested from foods. Higher than normal concentrations of MGO in the circulatory system and tissues have been found to be closely associated with the production of advanced glycation end products (AGEs), increased oxidative stress, elevated inflammation and RAGE (AGE receptors) activity, which subsequently progresses to a pathological stage of human health, such as diabetes complications, cancer, cardiovascular and degenerative diseases. Having illustrated the mechanisms of MGO trapping in vivo, we advocate the development of efficient and efficacious MGO scavengers, either assisting or enhancing the activity of endogenous glyoxalases to facilitate MGO removal, or providing phytochemicals and functional foods containing them, or pharmaceuticals to irreversibly bind MGO and thus form MGO-complexes that are cleared from the body.

Keywords

reactive carbonyl species / advanced glycation end products / diabetes, brain health / methylglyoxal trapping agents

References

[1] Wang Y, Ho C T. Flavour chemistry of methylglyoxal and glyoxal. Chemical Society Reviews, 2012, 41(11): 4140–4149

[2] Degen J, Hellwig M, Henle T. 1,2-Dicarbonyl compounds in commonly consumed foods. Journal of Agricultural and Food Chemistry, 2012, 60(28): 7071–7079

[3] Revel G D, Pripis-Nicolau L, Barbe J C, Bertrand A. The detection of a-dicarbonyl compounds in wine by formation of quinoxaline derivatives. Journal of the Science of Food and Agriculture, 2000, 80(1): 102–108

[4] Lo C Y, Li S, Wang Y, Tan D, Pan M H, Sang S, Ho C T. Reactive dicarbonyl compounds and 5-(hydroxymethyl)-2-furfural in carbonated beverages containing high fructose corn syrup. Food Chemistry, 2008, 107(3): 1099–1105

[5] Mavric E, Wittmann S, Barth G, Henle T. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Molecular Nutrition & Food Research, 2008, 52(4): 483–489

[6] Hayashi T, Shibamoto T. Analysis of methyl glyoxal in foods and beverages. Journal of Agricultural and Food Chemistry, 1985, 33(6): 1090–1093

[7] Löbner J, Degen J, Henle T. Creatine is a scavenger for methylglyoxal under physiological conditions via formation of N-(4-methyl-5-oxo-1-imidazolin-2-yl)sarcosine (MG-HCr). Journal of Agricultural and Food Chemistry, 2015, 63(8): 2249–2256

[8] Dornadula S, Elango B, Balashanmugam P, Palanisamy R, Kunka Mohanram R. Pathophysiological insights of methylglyoxal induced type-2 diabetes. Chemical Research in Toxicology, 2015, 28(9): 1666–1674

[9] Colzani M, De Maddis D, Casali G, Carini M, Vistoli G, Aldini G. Reactivity, selectivity, and reaction mechanisms of aminoguanidine, hydralazine, pyridoxamine, and carnosine as sequestering agents of reactive carbonyl species: a comparative study. ChemMedChem, 2016, 11(16): 1778–1789

[10] Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes J W. Alterations in nonenzymatic biochemistry in uremia: origin and significance of “carbonyl stress” in long-term uremic complications. Kidney International, 1999, 55(2): 389–399

[11] Aldini G, Dalle-Donne I, Facino R M, Milzani A, Carini M. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Medicinal Research Reviews, 2007, 27(6): 817–868

[12] Thornalley P J. Monosaccharide autoxidation in health and disease. Environmental Health Perspectives, 1985, 64: 297–307

[13] Hayashi T, Namki M. Formation of two-carbon sugar fragment at an early stage of the browning reaction of sugar with amine. Agricultural and Biological Chemistry, 1980, 44(11): 2575–2580

[14] Saadat D, Harrison D H. The crystal structure of methylglyoxal synthase from Escherichia coli. Structure, 1999, 7(3): 309–317

[15] Phillips S A, Thornalley P J. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. European Journal of Biochemistry, 1993, 212(1): 101–105

[16] Hopper D J, Cooper R A. The regulation of Escherichia coli methylglyoxal synthase: a new control site in glycolysis? FEBS Letters, 1971, 13(4): 213–216

[17] Hopper D J, Cooper R A. The purification and properties of Escherichia coli methylglyoxal synthase. Biochemical Journal, 1972, 128(2): 321–329

[18] Tötemeyer S, Booth N A, Nichols W W, Dunbar B, Booth I R. From famine to feast: the role of methylglyoxal production in Escherichia coli. Molecular Microbiology, 1998, 27(3): 553–562

[19] Allaman I, Bélanger M, Magistretti P J. Methylglyoxal, the dark side of glycolysis. Frontiers in Neuroscience, 2015, 9: 23

[20] Thornalley P J. Dicarbonyl intermediates in the maillard reaction. Annals of the New York Academy of Sciences, 2005, 1043(1): 111–117

[21] Angeloni C, Zambonin L, Hrelia S. Role of methylglyoxal in Alzheimer’s disease. BioMed Research International, 2014, 2014(2014): 238485

[22] Klöpfer A, Spanneberg R, Glomb M A. Formation of arginine modifications in a model system of Na-tert-butoxycarbonyl (Boc)-arginine with methylglyoxal. Journal of Agricultural and Food Chemistry, 2011, 59(1): 394–401

[23] Vistoli G, De Maddis D, Cipak A, Zarkovic N, Carini M, Aldini G. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radical Research, 2013, 47(S1): 3–27

[24] Oya T, Hattori N, Mizuno Y, Miyata S, Maeda S, Osawa T, Uchida K. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. Journal of Biological Chemistry, 1999, 274(26): 18492–18502

[25] Shipanova I N, Glomb M A, Nagaraj R H. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Archives of Biochemistry and Biophysics, 1997, 344(1): 29–36

[26] Ahmed M U, Brinkmann Frye E, Degenhardt T P, Thorpe S R, Baynes J W. Nε-(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochemical Journal, 1997, 324(2): 565–570

[27] Nasiri R, Field M J, Zahedi M, Moosavi-Movahedi A A. Cross-linking mechanisms of arginine and lysine with a,b-dicarbonyl compounds in aqueous solution. Journal of Physical Chemistry A, 2011, 115(46): 13542–13555

[28] Nagaraj R H, Shipanova N, Faust F M. Protein cross-linking by the Maillard reaction isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal. Journal of Biological Chemistry, 196, 271(32): 19338–19345

[29] Lo T W, Westwood M E, McLellan A C, Selwood T, Thornalley P J. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. Journal of Biological Chemistry, 1994, 269(51): 32299–32305

[30] Nemet I, Varga-Defterdarović L. Methylglyoxal-derived b-carbolines formed from tryptophan and its derivates in the Maillard reaction. Amino Acids, 2007, 32(2): 291–293

[31] Ramasamy R, Yan S F, Schmidt A M. Methylglyoxal comes of AGE. Cell, 2006, 124(2): 258–260

[32] de Arriba S G, Stuchbury G, Yarin J, Burnell J, Loske C, Münch G. Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells--protection by carbonyl scavengers. Neurobiology of Aging, 2007, 28(7): 1044–1050

[33] Kaufmann E, Boehm B O, Süssmuth S D, Kientsch-Engel R, Sperfeld A, Ludolph A C, Tumani H. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neuroscience Letters, 2004, 371(2-3): 226–229

[34] Southern L, Williams J, Esiri M M. Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia. BMC Neurology, 2007, 7(1): 35

[35] Matafome P, Sena C, Seiça R. Methylglyoxal, obesity, and diabetes. Endocrine, 2013, 43(3): 472–484

[36] Sena C M, Matafome P, Crisóstomo J, Rodrigues L, Fernandes R, Pereira P, Seiça R M. Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharmacological Research, 2012, 65(5): 497–506

[37] Chang T, Wang R, Wu L. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Free Radical Biology & Medicine, 2005, 38(2): 286–293

[38] Dhar A, Desai K, Kazachmov M, Yu P, Wu L. Methylglyoxal production in vascular smooth muscle cells from different metabolic precursors. Metabolism: Clinical and Experimental, 2008, 57(9): 1211–1220

[39] Ward R A, McLeish K R. Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure? Nephrology, Dialysis, Transplantation, 2004, 19(7): 1702–1707

[40] Kalapos M P, Littauer A, de Groot H. Has reactive oxygen a role in methylglyoxal toxicity? A study on cultured rat hepatocytes. Archives of Toxicology, 1993, 67(5): 369–372

[41] Amicarelli F, Colafarina S, Cattani F, Cimini A, Di Ilio C, Ceru M P, Miranda M. Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radical Biology & Medicine, 2003, 35(8): 856–871

[42] Paget C, Lecomte M, Ruggiero D, Wiernsperger N, Lagarde M. Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radical Biology & Medicine, 1998, 25(1): 121–129

[43] Odani H, Shinzato T, Matsumoto Y, Usami J, Maeda K. Increase in three a,b-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochemical and Biophysical Research Communications, 1999, 256(1): 89–93

[44] Jia X, Olson D J, Ross A R, Wu L. Structural and functional changes in human insulin induced by methylglyoxal. FASEB Journal, 2006, 20(9): 1555–1557

[45] Oliveira L M, Lages A, Gomes R A, Neves H, Família C, Coelho A V, Quintas A. Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation. BMC Biochemistry, 2011, 12(1): 41

[46] Tóth A E, Tóth A, Walter F R, Kiss L, Veszelka S, Ózsvári B, Puskás L G, Heimesaat M M, Dohgu S, Kataoka Y, Rákhely G, Deli M A. Compounds blocking methylglyoxal-induced protein modification and brain endothelial injury. Archives of Medical Research, 2014, 45(8): 753–764

[47] Kuhla B, Lüth H J, Haferburg D, Boeck K, Arendt T, Münch G. Methylglyoxal, glyoxal, and their detoxification in Alzheimer’s disease. Annals of the New York Academy of Sciences, 2005, 1043(1): 211–216

[48] Münch G, Westcott B, Menini T, Gugliucci A. Advanced glycation endproducts and their pathogenic roles in neurological disorders. Amino Acids, 42(4): 1221–1236

[49] Vitek M P, Bhattacharya K, Glendening J M, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 1994, 91(11): 4766–4770

[50] Naudí A, Jové M, Cacabelos D, Ayala V, Cabre R, Caro P, Gomez J, Portero-Otín M, Barja G, Pamplona R. Formation of S-(carboxymethyl)-cysteine in rat liver mitochondrial proteins: effects of caloric and methionine restriction. Amino Acids, 2013, 44(2): 361–371

[51] Negre-Salvayre A, Salvayre R, Augé N, Pamplona R, Portero-Otín M. Hyperglycemia and glycation in diabetic complications. Antioxidants & Redox Signalling, 2009, 11(12): 3071–3109

[52] Takamiya R, Takahashi M, Myint T, Park Y S, Miyazawa N, Endo T, Fujiwara N, Sakiyama H, Misonou Y, Miyamoto Y, Fujii J, Taniguchi N. Glycation proceeds faster in mutated Cu, Zn-superoxide dismutases related to familial amyotrophic lateral sclerosis. FASEB Journal, 2003, 17(8): 938–940

[53] Kikuchi S, Shinpo K, Ogata A, Tsuji S, Takeuchi M, Makita Z, Tashiro K. Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2002, 3(2): 63–68

[54] Kalousová M, Zima T, Tesař V, Dusilová-Sulková S, Škrha J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutation Research, 2005, 579(1-2): 37–46 doi:10.1016/j.mrfmmm.2005.03.024

[55] Andersson A, Covacu R, Sunnemark D, Danilov A I, Dal Bianco A, Khademi M, Wallström E, Lobell A, Brundin L, Lassmann H, Harris R A. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. Journal of Leukocyte Biology, 2008, 84(5): 1248–1255

[56] Münch G, Lüth H J, Wong A, Arendt T, Hirsch E, Ravid R, Riederer P. Crosslinking of a-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation? Journal of Chemical Neuroanatomy, 2000, 20(3–4): 253–257

[57] Dalfó E, Portero-Otín M, Ayala V, Martínez A, Pamplona R, Ferrer I. Evidence of oxidative stress in the neocortex in incidental Lewy body disease. Journal of Neuropathology and Experimental Neurology, 2005, 64(9): 816–830

[58] Dukic-Stefanovic S, Schinzel R, Riederer P, Münch G. AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs? Biogerontology, 2001, 2(1): 19–34

[59] Wu C H, Yen G C. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. Journal of Agricultural and Food Chemistry, 2005, 53(8): 3167–3173

[60] Sang S, Shao X, Bai N, Lo C Y, Yang C S, Ho C T. Tea polyphenol (-)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species. Chemical Research in Toxicology, 2007, 20(12): 1862–1870

[61] Lv L, Shao X, Chen H, Ho C T, Sang S. Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chemical Research in Toxicology, 2011, 24(4): 579–586

[62] Li X, Zheng T, Sang S, Lv L. Quercetin inhibits advanced glycation end product formation by trapping methylglyoxal and glyoxal. Journal of Agricultural and Food Chemistry, 2014, 62(50): 12152–12158

[63] Shao X, Bai N, He K, Ho C T, Yang C S, Sang S. Apple polyphenols, phloretin and phloridzin: new trapping agents of reactive dicarbonyl species. Chemical Research in Toxicology, 2008, 21(10): 2042–2050

[64] Wang P, Chen H, Sang S. Trapping methylglyoxal by genistein and its metabolites in mice. Chemical Research in Toxicology, 2016, 29(3): 406–414

[65] Lo C Y, Hsiao W T, Chen X Y. Efficiency of trapping methylglyoxal by phenols and phenolic acids. Journal of Food Science, 2011, 76(3): H90–H96

[66] Shao X, Chen H, Zhu Y, Sedighi R, Ho C T, Sang S. Essential structural requirements and additive effects for flavonoids to scavenge methylglyoxal. Journal of Agricultural and Food Chemistry, 2014, 62(14): 3202–3210

Acknowledgements

This work was supported by the USDA National Institute of Food and Agriculture, Hatch project 1007898.

Compliance with ethics guidelines

Shiming Li, Siyu Liu, and Chi-Tang Ho declare that they have no conflicts of interest or financial conflicts to disclose.

This article is a review and does not contain any studies with human or animal subjects performed by any of the authors.

RIGHTS & PERMISSIONS

The Author(s) 2017. Published by Higher Education Press. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0)